SCHEMBL60267

SCHEMBL60267

Cc1ccc(C(=O)[O-])cc1Oc1ccccc1.[Na+]

nearest known ligand 0.51

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 2/20 0.44
CA4 known ✓ P22748 1/20 0.44
CA1 known ✓ P00915 1/20 0.42
TTR P02766 2/20 0.51
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NR1H4 Q96RI1 1/20 0.43
RXRA P19793 2/20 0.43
LMNA P02545 1/20 0.42
LPAR1 Q92633 1/20 0.41
LPAR5 Q9H1C0 1/20 0.41
PARP10 Q53GL7 1/20 0.41
SRD5A2 P31213 2/20 0.41
LDLR P01130 1/20 0.41
KIT P10721 1/20 0.41
PCSK9 Q8NBP7 1/20 0.41
RXRB P28702 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8508445 0.85 TTR (0.69) TTRCYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL13138860 0.84 TTR (0.54) TTRCYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL27414055 0.84 TTR (0.67) TTRCYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL21363204 0.81 NOTUM (0.57) TTRCYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL11602845 0.81 CA2 (0.53) CYP1A2CYP2C9CYP2C19SMN1; SMN2CA2
SCHEMBL1172207 0.80 KMT2A (0.58) SMN1; SMN2NPSR1CA2CA4RXRA
SCHEMBL7663053 0.80 ERCC5 (0.64) TTRCYP1A2CYP2C9CYP2C19SMN1; SMN2
Potassium Ion SCHEMBL11603948 0.78 LPAR1 (0.52) CYP1A2CYP2C9CYP2C19SMN1; SMN2CA2
SCHEMBL14894871 0.77 SMN1; SMN2 (0.52) SMN1; SMN2CA2CA4LMNA
M-Phenoxybenzoic Acid For Cis-Isomer SCHEMBL9764602 0.75 AKR1C3 (0.70) SMN1; SMN2CA2CA4LMNAPARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060288743-A1 Peroxide generating device and method CONOPCO INC. D/B/A UNILEVER 2006-12-28 US claimed
US-20040180803-A1 Laundry detergent compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2004-09-16 US claimed
EP-1412466-A1 LAUNDRY DETERGENT COMPOSITIONS UNILEVER PLC (GB) 2004-04-28 EP claimed
WO-2003014283-A1 LAUNDRY DETERGENT COMPOSITIONS UNILEVER PLC (GB) 2003-02-20 WO claimed
EP-4110831-B1 DEGRADATIVE METHOD CATEXEL TECH LIMITED (GB) 2024-02-21 EP disclosed
US-20230095399-A1 DEGRADATIVE METHOD CATEXEL TECHNOLOGIES LIMITED (GB) 2023-03-30 US disclosed
EP-3033409-B1 COMPOSITION CATEXEL TECH LIMITED (GB) 2021-09-22 EP disclosed
EP-3011004-B2 BLEACH AND OXIDATION CATALYST CATEXEL TECH LIMITED (GB) 2020-07-01 EP disclosed
EP-3524347-A1 USE OF METAL HYDRAZIDE COMPLEX COMPOUNDS AS OXIDATION CATALYSTS BASF SE (DE) 2019-08-14 EP disclosed
US-10370621-B2 Bleaching formulations comprising particles and transition metal ion-containing bleaching catalysts CHEMSENTI LIMITED (GB) 2019-08-06 US disclosed
EP-2271426-B1 USE OF HYDRAZIDE COMPOUNDS AS OXIDATION CATALYSTS BASF SE (DE) 2019-02-20 EP disclosed
EP-2771445-B1 USE OF COMB OR BLOCK COPOLYMERS AS SOIL ANTIREDEPOSITION AGENTS AND SOIL RELEASE AGENTS IN LAUNDRY PROCESSES HENKEL AG & CO KGAA (DE) 2018-12-12 EP disclosed
US-5580485-A IRON-COMPLEXES; OXIDATION CATALYSTS LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1996-12-03 US disclosed
WO-1996025481-A1 SOLID DETERGENT BLOCK UNILEVER N.V. (NL) 1996-08-22 WO disclosed
WO-1996006157-A1 DETERGENT BLEACH COMPOSITION UNILEVER N.V. (NL) 1996-02-29 WO disclosed
WO-1996006154-A1 DETERGENT BLEACH COMPOSITION UNILEVER N.V. (NL) 1996-02-29 WO disclosed
WO-1995034628-A1 BLEACH ACTIVATION UNILEVER N.V. (NL) 1995-12-21 WO disclosed
EP-0549271-A1 Bleach activation UNILEVER PLC (GB) 1993-06-30 EP disclosed
EP-0549272-A1 Bleach activation UNILEVER PLC (GB) 1993-06-30 EP disclosed
EP-0544490-A1 Detergent bleach compositions UNILEVER PLC (GB) 1993-06-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230095399-A1 DEGRADATIVE METHOD MPO, LPO, PPOX CA2 697/4885CA4 324/4885CA1 678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.